Nature Communications (Jan 2024)

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

  • Nicolai Franzmeier,
  • Amir Dehsarvi,
  • Anna Steward,
  • Davina Biel,
  • Anna Dewenter,
  • Sebastian Niclas Roemer,
  • Fabian Wagner,
  • Mattes Groß,
  • Matthias Brendel,
  • Alexis Moscoso,
  • Prithvi Arunachalam,
  • Kaj Blennow,
  • Henrik Zetterberg,
  • Michael Ewers,
  • Michael Schöll

DOI
https://doi.org/10.1038/s41467-023-44374-w
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 10

Abstract

Read online

Abstract In Alzheimer’s disease, amyloid-beta (Aβ) triggers the trans-synaptic spread of tau pathology, and aberrant synaptic activity has been shown to promote tau spreading. Aβ induces aberrant synaptic activity, manifesting in increases in the presynaptic growth-associated protein 43 (GAP-43), which is closely involved in synaptic activity and plasticity. We therefore tested whether Aβ-related GAP-43 increases, as a marker of synaptic changes, drive tau spreading in 93 patients across the aging and Alzheimer’s spectrum with available CSF GAP-43, amyloid-PET and longitudinal tau-PET assessments. We found that (1) higher GAP-43 was associated with faster Aβ-related tau accumulation, specifically in brain regions connected closest to subject-specific tau epicenters and (2) that higher GAP-43 strengthened the association between Aβ and connectivity-associated tau spread. This suggests that GAP-43-related synaptic changes are linked to faster Aβ-related tau spread across connected regions and that synapses could be key targets for preventing tau spreading in Alzheimer’s disease.